Literature DB >> 8912901

Amyloid load and neural elements in Alzheimer's disease and nondemented individuals with high amyloid plaque density.

A Mochizuki1, J W Peterson, E J Mufson, B D Trapp.   

Abstract

The amyloid burden and relationship between amyloid deposits and neural elements were investigated in sections of prefrontal neocortex from eight Alzheimer's disease (AD) patients and four age-matched nondemented controls with high amyloid plaque density (HPND). Computer-based image analysis revealed that the total area occupied by betaA4 immunoreactivity was significantly greater (P < 0.031) in AD (27.1%) than in HPND (14.5%) sections. The total betaA4-positive area occupied by nondiffuse plaques was significantly greater (P < 0.05) in AD (13.6%) than in HPND (5.2%) sections. The percentage of diffuse (DPs) and nondiffuse plaques (NDPs) which contained neurons, astrocytes, microglia, dystrophic neurites, and amyloid precursor protein (APP) was also determined. The frequency of association between betaA4 and these neural elements was similar between AD and HPND cases in both diffuse and nondiffuse plaques. Forty percent of DPs in AD and HPND sections contained neuronal perikarya. Microglia, dystrophic neurites, and APP were detected in most nondiffuse plaques in both AD and HPND sections. While astrocyte cell bodies were not present in either diffuse or nondiffuse plaques, their processes were detected in most. These findings indicate that amyloid deposition and nondiffuse plaques are greater in AD than in HPND sections. The association between microglia and nondiffuse plaques supports the hypothesis that these resident immune cells participate in aggregation and redistribution of amyloid deposits and possibly formation of dystrophic neurites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912901     DOI: 10.1006/exnr.1996.0181

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  13 in total

1.  Resistance to Alzheimer's pathology is associated with nuclear hypertrophy in neurons.

Authors:  Miguel Angel Riudavets; Diego Iacono; Susan M Resnick; Richard O'Brien; Alan B Zonderman; Lee J Martin; Gay Rudow; Olga Pletnikova; Juan C Troncoso
Journal:  Neurobiol Aging       Date:  2007-06-28       Impact factor: 4.673

2.  Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease.

Authors:  Steven E Arnold; Natalia Louneva; Kajia Cao; Li-San Wang; Li-Ying Han; David A Wolk; Selamawit Negash; Sue E Leurgans; Julie A Schneider; Aron S Buchman; Robert S Wilson; David A Bennett
Journal:  Neurobiol Aging       Date:  2012-05-02       Impact factor: 4.673

Review 3.  Neuropathological correlates of amyloid PET imaging in Down syndrome.

Authors:  Eric E Abrahamson; Elizabeth Head; Ira T Lott; Benjamin L Handen; Elliott J Mufson; Bradley T Christian; William E Klunk; Milos D Ikonomovic
Journal:  Dev Neurobiol       Date:  2019-08-17       Impact factor: 3.964

4.  Na,K-ATPase mRNA levels and plaque load in Alzheimer's disease.

Authors:  N B Chauhan; J M Lee; G J Siegel
Journal:  J Mol Neurosci       Date:  1997-12       Impact factor: 3.444

5.  Caveolin-3 upregulation activates beta-secretase-mediated cleavage of the amyloid precursor protein in Alzheimer's disease.

Authors:  K Nishiyama; B D Trapp; T Ikezu; R M Ransohoff; T Tomita; T Iwatsubo; I Kanazawa; K K Hsiao; M P Lisanti; T Okamoto
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

6.  Microglial response to amyloid plaques in APPsw transgenic mice.

Authors:  S A Frautschy; F Yang; M Irrizarry; B Hyman; T C Saido; K Hsiao; G M Cole
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

7.  Neuronal hypertrophy in asymptomatic Alzheimer disease.

Authors:  Diego Iacono; Richard O'Brien; Susan M Resnick; Alan B Zonderman; Olga Pletnikova; Gay Rudow; Yang An; Mark J West; Barbara Crain; Juan C Troncoso
Journal:  J Neuropathol Exp Neurol       Date:  2008-06       Impact factor: 3.685

8.  Alzheimer's disease (AD)-like pathology in aged monkeys after infantile exposure to environmental metal lead (Pb): evidence for a developmental origin and environmental link for AD.

Authors:  Jinfang Wu; Md Riyaz Basha; Brian Brock; David P Cox; Fernando Cardozo-Pelaez; Christopher A McPherson; Jean Harry; Deborah C Rice; Bryan Maloney; Demao Chen; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

9.  Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortex.

Authors:  Elaine Leung; Ling Guo; Jing Bu; Marie Maloof; Joseph El Khoury; Changiz Geula
Journal:  Neurobiol Aging       Date:  2009-04-05       Impact factor: 4.673

10.  Synthesis and evaluation of 2-(3'-iodo-4'-aminophenyl)-6-hydroxybenzothiazole for in vivo quantitation of amyloid deposits in Alzheimer's disease.

Authors:  Yanming Wang; William E Klunk; Guo-Feng Huang; Manik L Debnath; Daniel P Holt; Chester A Mathis
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.